Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases

International Immunopharmacology

Volumn 6, Issue 4, 2006, Pages 600-606

  Daoud, Yassine J ^a,c,d   Amin, Ketan G ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c NEW ENGLAND BAPTIST HOSPITAL   (United States)

^d Center for Blistering Diseases   (United States)

Author keywords

Autoimmune mucocutaneous blistering diseases; Conventional immunosuppressive therapy; Cost of side effects; Intravenous immunoglobulin therapy; Pharmacoeconomics; Total cost of care

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; AUTOIMMUNE MUCOCUTANEOUS BLISTERING DISEASE; AUTOIMMUNE SKIN DISEASE; BULLOUS SKIN DISEASE; CICATRICIAL PEMPHIGOID; COHORT ANALYSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DISEASE COURSE; DRUG COST; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LONG TERM CARE; PEMPHIGOID; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT;

AGED; AUTOIMMUNE DISEASES; COSTS AND COST ANALYSIS; DRUG COSTS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; SKIN DISEASES;

EID: 33644545373     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.11.002     Document Type: Article

References (37)

1. S. Tyagi, K. Bhol, K. Natarajan, C. Livir-Rallatos, C.S. Foster, and A.R. Ahmed Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization Proc Natl Acad Sci U S A 93 1996 14714 14719
2. T.E. Fleming, and N.J. Korman Cicatricial pemphigoid J Am Acad Dermatol 43 2000 571 591
3. A.R. Ahmed, B.S. Kurgis, and R.S. Rogers Cicatricial pemphigoid J Am Acad Dermatol 24 1991 987 1001
4. H.C. Nousari, and G.J. Anhalt Pemphigus and bullous pemphigoid Lancet 354 1999 667 672
5. W.F. Lever Pemphigus and pemphigoid J Am Acad Dermatol 1 1979 2 31
6. N.J. Korman Bullous pemphigoid: the latest in diagnosis, prognosis, and therapy Arch Dermatol 134 1998 1137 1141
7. C.S. Foster, L.A. Wilson, and M.B. Ekins Immunosuppressive therapy for progressive ocular cicatricial pemphigoid Ophthalmology 89 1982 340 353
8. C.S. Foster, and A.R. Ahmed Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study Ophthalmology 106 1999 2136 2143
9. B.J. Mondino, and S.I. Brown Immunosuppressive therapy in ocular cicatricial pemphigoid Am J Ophthalmol 96 1983 453 459
10. C.S. Foster, R. Neumann, and J. Tauber Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid Doc Ophthalmol 82 1992 223 229
11. J. Tauber, M. Sainz de la Maza, and C.S. Foster Systemic chemotherapy for ocular cicatricial pemphigoid Cornea 10 1991 185 195
12. A. Herbst, and J.C. Bystryn Patterns of remission in pemphigus vulgaris J Am Acad Dermatol 42 2000 422 427
13. R.L. Colbert, F.M. Allen, D. Eastwood, and J.A. Farley Mortality rate of bullous pemphigoid in a U.S. medical center J Invest Dermatol 122 2004 1091 1095
14. R.A. Swerlick, and N.J. Korman Bullous pemphigoid: what is the prognosis? J Invest Dermatol 122 5 2004 xvii xviii
15. N. Sami, K.C. Bhol, and A.R. Ahmed Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid Clin Immunol 102 2002 59 67
16. N. Sami, E. Letko, S. Androudi, Y. Daoud, C.S. Foster, and A.R. Ahmed Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a long-term follow-up Ophthalmology 111 2004 1380 1382
17. A.R. Ahmed Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive therapy J Am Acad Dermatol 45 2001 825 838
18. A.R. Ahmed Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment J Am Acad Dermatol 45 2001 679 690
19. N. Sami, A. Qureshi, E. Ruocco, and A.R. Ahmed Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris Arch Dermatol 138 2002 1158 1162
20. R. Neumann, J. Tauber, and C.S. Foster Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid Ophthalmology 98 1991 858 862
21. B.J. Mondino Cicatricial pemphigoid and erythema multiforme Ophthalmology 97 1990 939 952
22. 2001 Drug Topics® Red Book®. New Jersey: Medical Economics Company Inc.; 2001. Rx Product Listing; pp. 163-569.
23. Massachusetts Division of HealthCare Finance and Policy: the FY99 PC Acute hospital payer, utilization, and discharge data product. Available at: http://www.mass.gov/dhcfp/pages/dhcfp_59.htm#anchor2258792. Accessed on October 4, 2001.
24. United States Bureau of Labor Statistics: Economic news release. Available at: ftp://ftp.bls.gov/pub/news.release/History/cpi.01172001.news. Accessed on August 2005.
25. HCIA The guide to the managed care industry 1999 Solucient Baltimore, MD 13
26. Centers for Medicare and Medicaid Services (CMS), Office of the Actuary, National Health Statistics Group, National Health Accounts. Available at: http://www.cms.hhs.gov/statistics/nhe/historical/chart.asp. Accessed on March 8, 2005.
27. A.R. Ahmed, and M.V. Dahl Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases Arch Dermatol 139 2003 1051 1059
28. B. Rosner Fundamentals of biostatistics 5th ed. 2000 Duxbury Publishing Pacific Grove, CA 275 279
29. J.E. Scott, and A.R. Ahmed The blistering diseases Med Clin North Am 82 1998 1239 1283
30. J.A. Savin The events leading to the death of patients with pemphigus and pemphigoid Br J Dermatol 101 1979 521 534
31. A.J. Kanwar, and S. Dhar Factors responsible for death in patients with pemphigus J Dermatol 21 1994 655 659
32. F.M. Weeks, G.C. Yee, A.A. Bartfield, and J.R. Wingard True cost of bone marrow transplantation Am J Med Sci 314 1997 101 112
33. H.G. Welch, and E.B. Larson Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia N Engl J Med 321 1989 807 812
34. Centers of Medicare and Medicaid Services. Department of Health and Human Services. Coverage issues manual. Available at http://www.cms.hhs.gov/manuals/ 06_cim/ci35.asp#_1_1 Part 35-30.1 Rev. 138. Accessed on May 29, 2004.
35. Prevalence and cost of ESRD therapy Am J Kidney Dis 18 1991 21 29
36. R.H. Hu, P.H. Lee, M.K. Tsai, and C.Y. Lee Medical costs between renal transplantation and hemodialysis Transplant Proc 30 1998 3617 3620
37. W.C. Winkelmayer, M.C. Weinstein, M.A. Mittleman, R.J. Glynn, and J.S. Pliskin Health economic evaluations: the special case of end stage renal disease treatment Med Decis Mak 22 2002 417 430